<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506182/" ref="ordinalpos=3754&amp;ncbi_uid=5306549&amp;link_uid=PMC3506182" image-link="/pmc/articles/PMC3506182/figure/F2/" class="imagepopup">Figure 2. CCN6 regulates BMP4-mediated TAK1 and p38 activation.  From: CCN6 modulates BMP <span class="highlight" style="background-color:">signaling</span> via the Smad-independent TAK1/p38 <span class="highlight" style="background-color:">pathway</span>, acting to suppress metastasis of breast cancer. </a></div><br /><div class="p4l_captionBody"><b>A.</b> Quantitative real time PCR array of TGF-β/BMP pathway genes reveal that CCN6 KD principally leads to upregulation of BMP4 and BMP-regulated genes in HME cells. No significant effect was observed on the mRNA levels of TGF-β1, TGF-β2, BMP1, 2, 3, 5 and 6 genes, or co-receptor Smads between HME CCN6 KD and controls. <b>B.</b> Immunnoblots of HME and MDA-MB-231 cells show that CCN6 mainly regulates BMP4 protein and its non-Smad signaling proteins P-TAK1 and P-p38 MAPK.</div></div>